Page 10 - Pfizer

UK to offer Pfizer's Covid-19 vaccine shots to at-risk children aged 5-11

The UK Health Security Agency allowed the use of smaller doses of Pfizer's Covid-19 vaccines in children aged 5 to 11 who are at a higher risk from the virus

Pfizer pill becomes 1st US-authorised home Covid-19 treatment

The drug, Paxlovid, is a faster, cheaper way to treat early Covid-19 infections

LIVE: 8 more Omicron cases in Maharashtra, 6 in Karnataka, 4 in Kerala

Of the six cases in Karnataka, one is a passenger from the UK, while five others have been detected from Covid clusters that have emerged from two educational institutions in Dakshina Kannada district

Pfizer Inc says coronavirus pandemic could extend to 2024

Vaccine data for younger children delayed, says Pfizer

Pfizer study tests extra Covid-19 vaccine dose for kids under 5

For children younger than 5, Pfizer is testing an even smaller dose, just 3 micrograms or a tenth of the adult dose

CDC panel recommends Pfizer, Moderna Covid vaccines over J&J shot

Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health advisers recommended Thursday. The strange clotting problem has caused nine confirmed deaths after J&J vaccinations while the Pfizer and Moderna vaccines don't come with that risk and also appear to be more effective, advisers to the Centers for Disease Control and Prevention said. It's an unusual move and the CDC's director, Dr. Rochelle Walensky, must decide whether to accept the panel's advice. Until now the U.S. has treated all three COVID-19 vaccines available to Americans as an equal choice, since large studies found they all offered strong protection and early supplies were limited. J&J's vaccine initially was welcomed as a single-dose option that could be especially important for hard-to-reach groups like homeless people who might not get the needed second dose of the Pfizer or Moderna options. But the CDC's ..

Booster shots for 40+ and frontline workers to cost govt another Rs 10k cr

If booster shots are given on priority, the pace of vaccination may slow further. In the worst case scenario, the country will take till mid-March to vaccinate its entire adult population partially.

Pfizer's Covid-19 antiviral pill marks significant step forward: Biden

US President Joe Biden on Tuesday (local time) said that Pfizer's COVID-19 antiviral pill mark a significant step forward in the path out of the pandemic.

Pfizer Covid pill nearly 90% effective, works on Omicron, shows lab data

The updates come as Covid cases, deaths and hospitalization are all rising again and the US hovers around 800,000 pandemic deaths

Top headlines: PCA framework for NBFCs; Nov WPI inflation spikes to 14.23%

Business Standard brings you the top headlines on Tuesday

Two doses of Covid vax induce lower antibody levels against Omicron: Study

Two doses of Pfizer AstraZeneca Covid vaccines generate lower levels of antibodies against the Omicron variant of coronavirus.

Pfizer to acquire Arena Pharmaceuticals at 100% premium in $6.7-bn deal

The U.S. drugmaker will pay $100 a share in an all-cash transaction for San Diego-based Arena, bringing assets in gastroenterology, dermatology and cardiology

Booster shot of Pfizer can cut mortality from Delta variant by 90%: Study

The third dose of the Pfizer Covid-19 vaccine can reduce mortality due to the Delta variant of the SARS-CoV-2 virus by 90 per cent, according to a study conducted in Israel.

Three-shot course of Pfizer's Covid-19 vaccine neutralises Omicron variant

BioNTech and Pifzer are the first manufacturers of a Covid vaccine to issue an official update on the efficacy of their shot against Omicron

Covid: Pfizer, BioNTech say third dose neutralises Omicron variant

A booster with the current version of the vaccine increased antibodies 25-fold, providing a similar level as observed after two doses

Pfizer vaccine may only partially protect against Omicron variant: Study

South Africa research shows that blood from people who had received two doses of the vaccine and had a prior infection were mostly able to neutralise the variant.

Pfizer faces scrutiny over scale of its Covid profits, says report

Pfizer has to date pledged 40m doses out of global production to Covax

Booster dose of six Covid vaccines safe, increases immunity: Lancet study

Six different COVID-19 boosters are safe and elicit strong immune response in people who have previously received a two-dose course of AstraZeneca or Pfizer vaccines.

Delta variant may have increased ability to evade vaccine immunity: Study

Vaccines are effective in decreasing hospitalization and deaths from Covid-19 infection but the emergence of viral variants of concern may diminish their efficacy, according to a recent study.

UK study finds mRNA Covid-19 vaccines provide biggest booster impact

Pfizer and Moderna shots give large antibody boosts regardless of whether a person initially received those vaccines.